Skip to main content

Practice Tips

  • Diplomat announces executive promotion for Jennifer Hagerman

    FLINT, Mich. — Diplomat Pharmacy announced Tuesday that Jennifer Hagerman had been promoted to be the company’s VP education and quality. In her new role, Hagerman will oversee the company’s employee and external professional education and training program, Diplomat University. This area also contains the company’s quality assurance department. 
     
  • Researchers find four supplements that boost efficacy of antidepressants

    PARKVILLE, Australia - An international evidence review has found that certain nutritional supplements can increase the effectiveness of antidepressants for people with clinical depression.
     
    Omega 3 fish oils, S-adenosylmethionine (SAMe), methylfolate (bioactive form of folate) and vitamin D, were all found to boost the effects of medication.
     
  • Tris Pharma launches Dyanavel XR

    MONMOUTH JUNCTION, N.J. — Tris Pharma announced this week that it had launched its Dyanavel XR (amphetamine) extended-release liquid for oral suspension. The drug is indicated to treat attention deficit/hyperactivity disorder (ADHD) in children aged 6 years and older
     
  • Oska introduces wearable pain relief device

    SAN DIEGO - Oska Wellness on Tuesday introduced Oska Pulse, a wearable pain relief device is designed to help reduce muscle stiffness, temporarily relieve minor pain and increase mobility. Using proprietary eTec Pulse Technology, Oska Pulse is a small, portable device that safely optimizes Pulsed Electromagnetic Field therapeutic technology. 
     
  • ePrescribing Message Types: An Expanding Opportunity

    Better industry collaboration equates to better patient care and lower costs. This industry-recognized truth is especially true within medication management processes, where errors and preventable adverse events are a focal point of national attention.

  • Benzer Pharmacy adds med sync program

    TAMPA, Fla. — Benzer Pharmacy announced Wednesday that it would be adding to the services it offers patients, introducing a medication synchronization program aimed at increasing patient adherence and streamlining the process of picking up multiple medications. 
     
  • Mylan launches generic extended-release Ultram

    PITTSBURGH — Mylan on Tuesday announced the launch of its generic of Ultram (tramadol hydrochloride) extended-release tablets in the United States. The drug is indicated to treat moderate to moderately sever chronic pain who require constant treatment for extended time periods. 
     
    Mylan’s generic will be available in 100-, 200- and 300-mg dosage strength. The drug had annual U.S. sales of about $52.8 million for the 12 months ended Dec. 31, 2015, according to IMS Health. 
     
X
This ad will auto-close in 10 seconds